Simple Science

Cutting edge science explained simply

# Biology# Genetics

Investigating Compounds that Influence Aging

Research explores compounds, particularly atRA, that may extend lifespan and improve health.

Patrick C Phillips, S. A. Banse, C. A. Sedore, A. Coleman-Hulbert, E. Johnson, B. Onken, D. Hall, E. Segerdell, E. G. Jackson, Y. Song, H. C. Osman, J. Xue, E. Basttistoni, S. Guo, A. Foulger, M. Achanta, M. Sheikh, T. Fitzgibbon, J. H. Willis, G. C. Woodruff, M. Driscoll, G. Lithgow

― 7 min read


Compounds AffectingCompounds AffectingLifespan Uncoveredage-extending compounds in research.New findings reveal potential
Table of Contents

Aging is a major factor in many health issues, illnesses, and even death. Recent studies suggest that aging itself can be treated, potentially leading to improvements in various age-related health problems. This idea is called the “geroscience hypothesis.” But how can researchers find the right compounds that might help extend lifespan and health? While using model organisms like the tiny roundworm, Caenorhabditis Elegans, provides insights, researchers are also looking at databases that track the effects of different compounds. These databases can help predict which compounds might be beneficial in extending lifespan.

An important aspect of this research is the quality of the data being used. Aging is complex, and it can be challenging to reproduce results consistently. The Caenorhabditis Intervention Testing Program (CITP) is focused on testing how different compounds can influence lifespan and health across various strains of these nematodes. The CITP works hard to ensure that response to treatments is reliable and can be repeated in different labs.

Initial Steps in Compound Testing

To start their investigation, researchers used a previous list of compounds that were thought to have potential in extending lifespan based on drug and aging-related gene interactions. They created a shortlist of 16 candidate compounds, including known drugs and newly identified ones, for further testing. Among these compounds, some showed significant promise in extending lifespan when tested on C. elegans.

While testing these compounds, researchers discovered that out of the initial candidates, five compounds extended lifespan significantly. Among these, Propranolol and all-trans retinoic acid (atRA) had the most substantial positive effects. However, potential interactions between propranolol and the bacteria that the worms eat prompted researchers to focus on atRA for further investigations.

What is all-trans Retinoic Acid?

All-trans retinoic acid is an FDA-approved drug used primarily in dermatology and cancer treatments. It is derived from vitamin A and plays a significant role in regulating various biological processes. Studies showed that C. elegans has certain genes related to vitamin A metabolism, suggesting the presence of a signaling pathway that responds to atRA.

Although the pathway processes involving atRA are well-studied in mammals, some key components might be missing in C. elegans, making it difficult to draw direct comparisons. However, some related proteins in C. elegans can still be used to understand how atRA affects lifespan.

Examining the Impact of atRA on Lifespan

Building on earlier work, researchers conducted an in-depth analysis of how atRA affects Longevity. They found that the positive effects of atRA on lifespan required specific gene functions related to two important kinases, akt-1, and akt-2, in C. elegans. These kinases are known to regulate vital aging pathways.

The studies indicated that while the FOXO/DAF-16 transcription factor, a well-known component of longevity pathways, was not essential for atRA's effects, other factors like the Nrf2 homolog SKN-1 and the heat shock factor HSF-1 were necessary for atRA to extend lifespan. This reinforced the idea that atRA affects longevity through complex signaling pathways similar to those found in mammals.

Identifying Lifespan-Extending Compounds

Researchers used the CITP system not only to test atRA but also to explore various other compounds that could potentially enhance lifespan. By beginning with a refined list of compounds based on computational predictions, researchers aimed to identify effective longevity interventions.

Among the compounds tested, some did not yield the desired results, while others, like atRA, showed promising outcomes. With a success rate of around 31% in terms of lifespan extension, the research demonstrated the potential of using predictive analytics in drug discovery for aging interventions.

The Role of Propranolol

Propranolol, a widely recognized drug for treating high blood pressure and anxiety, was of particular interest in the studies due to its significant impact on lifespan. However, as researchers investigated its effects, they realized that propranolol seemed to influence the growth of the bacteria that the worms fed on, complicating the assessment of its direct effects on lifespan.

To ensure accurate results, researchers conducted tests using bacteria that couldn’t grow. They found that under these conditions, propranolol did not provide the beneficial effects seen previously, suggesting that its lifespan-extending properties might be tied to its effects on bacterial growth rather than direct action on the worms.

Focusing on all-trans Retinoic Acid

In light of the findings regarding propranolol, researchers chose to concentrate on atRA for future studies. They examined how atRA affected various strains of C. elegans, finding that it consistently led to lifespan extensions across different genetic backgrounds. This highlights atRA’s promise as a compound with potential applications in the context of aging.

The research also sought to identify how atRA affected the health and performance of aging worms. Studies have shown that longevity interventions can lead to improvements in physical capabilities as well, demonstrating that atRA can positively impact both lifespan and healthspan.

The Mechanism Behind atRA’s Effects

Research showed that the effects of atRA on lifespan were dependent on the actions of specific proteins and signaling pathways. Key transcription factors, including SKN-1 and HSF-1, were found to be essential for atRA's action. An analysis of gene expression changes indicated that atRA treatment led to the modulation of several metabolic pathways related to longevity.

Researchers explored whether atRA’s effects on longevity were associated with known pathways involved in dietary restrictions, like the eat-2 mutant model, which affects feeding behavior. They found that atRA extended lifespan even in the presence of mutations that mimicked caloric restriction, suggesting that it operates through different mechanisms.

Gene Expression Changes Due to atRA

To gain a deeper understanding of atRA’s effects, researchers performed RNA sequencing to capture changes in gene expression. They found that atRA influenced a wide range of genes, particularly those associated with stress responses and metabolic processes. The majority of the upregulated genes were linked to metabolic functions that could improve the worm's health and longevity.

By analyzing the gene expression data, researchers could see how atRA not only extended lifespan but also improved overall health in the worms. However, they also noted that certain genes known to be involved in longevity did not follow expected patterns, suggesting complexity in how atRA operates at the molecular level.

The Importance of Signaling Pathways

Research pointed out that atRA could manipulate different signaling pathways that are critical for aging and lifespan. These included pathways controlled by AKT and AMPK, both of which play important roles in energy metabolism. The study also suggested that atRA might activate stress response systems that help protect cells against damage.

Moreover, the findings reinforced the notion that signaling mechanisms are interconnected, with atRA potentially affecting multiple pathways to exert its beneficial effects. This complexity could explain why some interventions show varying results across different models and contexts.

Next Steps in Aging Research

The findings suggest that atRA could be a valuable candidate for future studies focusing on aging. Given its established safety profile and existing FDA approval, researchers may eventually look at translating findings from C. elegans studies to larger models, including mice and, ultimately, humans.

As the field of aging research continues to grow, the integration of computational predictions with biological testing will likely become increasingly important. The systematic approach of combining drug screening and lifespan analysis in model organisms like C. elegans provides a rich avenue for discovering new longevity interventions.

With ongoing studies, researchers aim to better understand the specific molecular mechanisms behind atRA’s effects and to explore other compounds that might also contribute to extending lifespan and improving health as people age. This represents a hopeful frontier in the quest to enhance the quality of life for aging populations around the world.

Original Source

Title: Computer prediction and genetic analysis identifies retinoic acid modulation as a driver of conserved longevity pathways in genetically-diverse Caenorhabditis nematodes

Abstract: Aging is a pan-metazoan process with significant consequences for human health and society--discovery of new compounds that ameliorate the negative health impacts of aging promise to be of tremendous benefit across a number of age-based co-morbidities. One method to prioritize a testable subset of the nearly infinite universe of potential compounds is to use computational prediction of their likely anti-aging capacity. Here we present a survey of longevity effects for 16 compounds suggested by a previously published computational prediction set, capitalizing upon the comprehensive, multi-species approach utilized by the Caenorhabditis Intervention Testing Program (CITP). While eleven compounds (aldosterone, arecoline, bortezomib, dasatinib, decitabine, dexamethasone, erlotinib, everolimus, gefitinib, temsirolimus, and thalidomide) either had no effect on median lifespan or were toxic, five compounds (all-trans retinoic acid, berberine, fisetin, propranolol, and ritonavir) extended lifespan in Caenorhabditis elegans. These computer predictions yield a remarkable positive hit rate of 30%. Deeper genetic characterization of the longevity effects of one of the most efficacious compounds, the endogenous signaling ligand all-trans retinoic acid (atRA, designated tretinoin in medical products), which is widely prescribed for treatment of acne, skin photoaging and acute promyelocytic leukemia, demonstrated a requirement for the regulatory kinases AKT-1 and AKT-2. While the canonical Akt-target FOXO/DAF-16 was largely dispensable, other conserved Akt-targets (Nrf2/SKN-1 and HSF1/HSF-1), as well as the conserved catalytic subunit of AMPK AAK-2, were all necessary for longevity extension by atRA. Evolutionary conservation of retinoic acid as a signaling ligand and the structure of the downstream effector network of retinoic acid combine to suggest that the all-trans retinoic acid pathway is an ancient metabolic regulatory system that can modulate lifespan. Our results highlight the potential of combining computational prediction of longevity interventions with the power of nematode functional genetics and underscore that the manipulation of a conserved metabolic regulatory circuit by co-opting endogenous signaling molecules is a powerful approach for discovering aging interventions.

Authors: Patrick C Phillips, S. A. Banse, C. A. Sedore, A. Coleman-Hulbert, E. Johnson, B. Onken, D. Hall, E. Segerdell, E. G. Jackson, Y. Song, H. C. Osman, J. Xue, E. Basttistoni, S. Guo, A. Foulger, M. Achanta, M. Sheikh, T. Fitzgibbon, J. H. Willis, G. C. Woodruff, M. Driscoll, G. Lithgow

Last Update: 2024-10-26 00:00:00

Language: English

Source URL: https://www.biorxiv.org/content/10.1101/2024.10.23.619838

Source PDF: https://www.biorxiv.org/content/10.1101/2024.10.23.619838.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to biorxiv for use of its open access interoperability.

More from authors

Similar Articles